01696 SISRAM MED
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.61X | Oper Margin | 10.0% |
---|---|---|---|
LT Debt/Equity | 7.3% | Net Margin | 7.2% |
Total Debt/Equity | 9.3% | Return on Equity | 5.4% |
Price/Book | 0.70X | Return on Assets | 4.0% |
(HKD 5.350) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 195.05 | 246.10 | 313.23 | 243.60 | 103.44 |
---|---|---|---|---|---|
Net Profit Growth (%) | -20.7 | -21.4 | +28.6 | +135.5 | -36.1 |
Earnings Per Share (HKD) | 0.417 | 0.527 | 0.672 | 0.538 | 0.234 |
Earnings Per Share Growth (%) | -20.9 | -21.6 | +24.8 | +130.0 | -36.1 |
Dividend Per Share (HKD) | 0.126 | 0.158 | 0.173 | 0.157 | 0.070 |
P/E* (X) | 12.85 | 10.16 | 7.96 | 9.94 | 22.86 |
Yield (%) | 2.36 | 2.95 | 3.23 | 2.93 | 1.31 |
Dividend Share (%) | 30.25 | 30.00 | 25.75 | 29.17 | 29.91 |
Book NAV (HKD) | 7.692 | 7.546 | 7.190 | 6.727 | 5.819 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(USDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 349.112 | 359.292 | -2.8 | 354.48 |
Operating Result | 28.359 | 37.551 | -24.5 | 44.763 |
Associates | 0.03 | -0.421 | -107.1 | -0.521 |
Profit Before Taxation | 32.541 | 37.13 | -12.4 | 44.242 |
Taxation | 3.775 | 4.232 | -10.8 | 4.162 |
Profit /( Loss) After Taxation | 28.766 | 32.898 | -12.6 | 40.08 |
Minority Interests | 3.64 | 1.399 | +160.2 | -0.09 |
Net Profit | 25.126 | 31.499 | -20.2 | 40.17 |
Earnings Per Share () | 0.4165 | 0.5266 | -20.9 | 0.6718 |
Dividend Per Share () | 0.1260 | 0.1580 | -20.3 | 0.1730 |
Announcement Date | 2025-03-19 | 2024-03-20 | NA | 2023-03-21 |
* Annualised
Last Update Time: 2025-07-22 21:40:25